Skip to main content
  • Donate Blood (Opens in a new tab/window)
  • About NBA
  • News and updates
  • Resources
  • BloodPortal login (Opens in a new tab/window)
Logo image Logo image
  • Blood Products
    • Blood Products
    • National Product Price List
    • Fresh Blood Products
    • Albumin Products
    • Clotting Factor and Other Products
    • Immunoglobulin Products
      • Immunoglobulin Usage and Data
      • Intravenous Immunoglobulin (IVIg)
      • Subcutaneous Immunoglobulin (SCIg)
      • Normal Human Immunoglobulin (NHIg)
      • Hyperimmune Immunoglobulin Products
    • Access and Ordering
      • BloodSTAR for Ig Products
      • BloodSTAR Registration Form
      • BloodNet for Blood Products from Lifeblood
      • BloodNet System Interface
      • Frequently Asked Questions
    • Blood Product Management
      • Inventory Management
      • Blood Product Wastage
      • Blood and Inventory Management Resources
      • Case Studies
      • Single Unit Transfusion Guide
  • Supply System
    • Supply System
    • Managing Blood Supply
      • Risk Management
      • National Stewardship Program
      • Blood Product Labelling
    • Governance for Immunoglobulin Products
      • National Immunoglobulin Governance Committees
      • Criteria for Immunoglobulin Products
    • Suppliers and Commercial Supply Contracts
      • Fresh Blood Product Supply and Lifeblood
      • Plasma and Recombinant Product Supply
      • Imported Product Supply
      • Red Cell Diagnostic Product Supply
    • Australian Health Provider Access to Blood and Blood Products
    • Overseas Supply of Blood Products
  • Clinical Guidance
    • Clinical Guidance
      • Rh D Ig Guideline (Opens in a new tab/window)
      • PBM Guidelines (Opens in a new tab/window)
    • National Standards
    • Immunoglobulin
    • Patient Blood Management
      • Patient Blood Management (PBM) Resources
    • Transfusion-related Adverse Events
    • Bleeding Disorders
      • Australian Bleeding Disorders Registry (ABDR)
    • eLearning Courses
    • Public Consultations
    • Patient Blood Management Guidelines (Opens in a new tab/window)
  • Data and Research
    • Data and Research
    • Data and Reporting
    • Research Funding Program
      • Successful Grant Rounds
  • Patient Information
    • Patient information
      • Applying for overseas supply of blood products
    • Bleeding disorders
    • Blood disorders
    • Travelling with blood products
    • MyABDR app and the ABDR

Search

  • Donate Blood (Opens in a new tab/window)
  • About NBA
  • News and updates
  • Resources
  • BloodPortal login (Opens in a new tab/window)
  • Blood Products
    • Blood Products
    • National Product Price List
    • Fresh Blood Products
    • Albumin Products
    • Clotting Factor and Other Products
    • Immunoglobulin Products
      • Immunoglobulin Usage and Data
      • Intravenous Immunoglobulin (IVIg)
      • Subcutaneous Immunoglobulin (SCIg)
      • Normal Human Immunoglobulin (NHIg)
      • Hyperimmune Immunoglobulin Products
    • Access and Ordering
      • BloodSTAR for Ig Products
      • BloodSTAR Registration Form
      • BloodNet for Blood Products from Lifeblood
      • BloodNet System Interface
      • Frequently Asked Questions
    • Blood Product Management
      • Inventory Management
      • Blood Product Wastage
      • Blood and Inventory Management Resources
      • Case Studies
      • Single Unit Transfusion Guide
  • Supply System
    • Supply System
    • Managing Blood Supply
      • Risk Management
      • National Stewardship Program
      • Blood Product Labelling
    • Governance for Immunoglobulin Products
      • National Immunoglobulin Governance Committees
      • Criteria for Immunoglobulin Products
    • Suppliers and Commercial Supply Contracts
      • Fresh Blood Product Supply and Lifeblood
      • Plasma and Recombinant Product Supply
      • Imported Product Supply
      • Red Cell Diagnostic Product Supply
    • Australian Health Provider Access to Blood and Blood Products
    • Overseas Supply of Blood Products
  • Clinical Guidance
    • Clinical Guidance
      • Rh D Ig Guideline
      • PBM Guidelines
    • National Standards
    • Immunoglobulin
    • Patient Blood Management
      • Patient Blood Management (PBM) Resources
    • Transfusion-related Adverse Events
    • Bleeding Disorders
      • Australian Bleeding Disorders Registry (ABDR)
    • eLearning Courses
    • Public Consultations
    • Patient Blood Management Guidelines
  • Data and Research
    • Data and Research
    • Data and Reporting
    • Research Funding Program
      • Successful Grant Rounds
  • Patient Information
    • Patient information
      • Applying for overseas supply of blood products
    • Bleeding disorders
    • Blood disorders
    • Travelling with blood products
    • MyABDR app and the ABDR

Module 6 Neonatal and Paediatrics: Patient Blood Management Guidelines

  • Home
  • Module 6 Neonatal and Paediatrics: Patient Blood Management Guidelines

The final in a series of six evidence-based guidelines, the Neonatal and Paediatrics module’s recommendations were approved by the National Health and Medical Research Council (NHMRC) on 21 March 2016. The module was released on 29 April 2016. It is based on the best available evidence published up to June 2013.

The Neonatal and Paediatrics module is under review.  While the review is underway, the original version remains available to guide practice.

The Neonatal and Paediatrics module is intended to assist and guide health-care professionals in making clinical decisions about blood management in neonatal and paediatric patients.

The Neonatal and Paediatrics module includes six appendixes that provide guidance on dosing, assessment and optimisation of various products and situations in the neonatal and paediatric population. The Haemoglobin Assessment and Optimisation template (Appendix H) and the Critical Bleeding Protocol (Appendix K) are designed to be adapted to meet the needs of local institutions’ protocols, policies and procedures.

The Neonatal and Paediatrics module and accompanying resources can be accessed by clicking on the relevant links below.

 

Guideline

This guideline is now accessible on MAGICapp(Opens in a new tab/window). The electronic version on MAGICapp provides the same content as the original PDF version, including the erratum, below.

  • Module 6 Neonatal and Paediatrics (pdf)
    3.47 MB

Summary of clinical guidance

  • Quick Reference Guide Neonatal and Paediatrics (pdf)
    1.24 MB
  • Module 6 QRG Neonatal and Paediatrics erratum (updated May 2020) (pdf)
    36.99 KB

 

Publication order form

To request hard copies of the module or quick reference guide please click here to place your order. Due to limited stock, orders are restricted to Australia and New Zealand, and only 5 copies of each publication can be requested in a single order.

 

Paediatric haemoglobin assessment and optimisation template

  • Hb assessment and optimisation template (pptx)
    6.44 MB

Critical Bleeding Protocol template

  • Critical Bleeding Protocol template (pptx)
    6.45 MB

Technical Report

  • Technical Report Neonatal and Paediatrics - Volume 1 - Review of Evidence (pdf)
    8.25 MB
  • Technical Report Neonatal and Paediatrics - Volume 2 - Appendixes (pdf)
    9.95 MB

College & Society Endorsements

The National Blood Authority (NBA) greatly appreciates and acknowledges the input received from the clinical community in producing the Patient Blood Management Guidelines. We are pleased to acknowledge that the following organisations have formally endorsed Module 6 - Neonatal and Paediatrics.

  • Australasian College for Emergency Medicine
  • Australasian Society for Emergency Medicine
  • Australian and New Zealand Society of Blood Transfusion
  • Australian College of Children and Young People's Nurses
  • Australian College of Critical Care Nurses
  • Australian College of Rural & Remote Medicine
  • Australian Red Cross Lifeblood
  • College of Intensive Care Medicine of Australia and New Zealand
  • Royal Australasian College of Surgeons
  • Royal College of Pathologists of Australasia

Review and update of the PBM Guidelines

The NBA is currently considering the review and update process across the entire suite of modules rather than each module being updated in an isolated and iterative process. The aim is to transition to a sustainable and updateable methodology that will enable updates as the evidence base and clinical practice evolves. For more information please refer to the Patient Blood Management Guidelines Progress Update webpage.

PBM updates

Keep up to date with updates on patient blood management and our guidelines by subscribing to the PBM mailing list through BloodPortal(Opens in a new tab/window).

Get in touch

We welcome feedback on this guideline to inform future reviews or the development of materials to support implementation.

Email: guidelines@blood.gov.au

Last updated: 03 Jan 2025

The National Blood Authority acknowledges the Traditional Owners and Custodians of Country throughout Australia, and their continuing connection to land, water and community. We pay our respects to the people, the cultures and the elders past, present and emerging.

National Blood Authority

  • About the NBA
  • Work with us
  • Contact Us
  • Data and reporting
  • Freedom of information
  • Public interest disclosure
  • Resources
  • Accessibility
  • Privacy
  • Copyright
  • Disclaimer
  • BloodPortal Terms and Conditions of Use

Information

  • Blood Products
  • Managing blood supply
  • Supply systems
  • Clinical guidance
  • Patient information
  • Data and research
  • Website feedback